A dangerous prescription drug is one whose potential risks outweigh its possible benefits to the consumer. With the sheer number of pharmaceutical drugs on the market, the odds dictate that at least a portion of them will be defective or unreasonably dangerous.
The most frequent type of defect found in prescription drugs is when the manufacturer fails to warn consumers of the possible dangers the drug poses.
When a manufacturer fails to adequately investigate their product or fails to report adverse events or side effects, it is impossible to determine whether the benefits of the drug outweigh the risks, thereby placing consumers at risk of injury. Consumers who are injured as a result of the failure to warn may have a legal claim against the drug manufacturer.
A manufacturer may also face liability if it downplays or minimizes of a danger or side effect posed by the prescription drug, or markets the prescription drug for “off-label” uses. This is when the manufacturer persuades physicians to prescribe the drug for non FDA-approved purposes.
Doyle APC attorneys have been involved in the litigation of numerous defective pharmaceuticals and are currently investigating the following prescription drugs:
- Cordarone (heart medication)
- Pacerone (heart medication)
- Amiodarone (heart medication)
- Pradaxa (an anti-coagulant)
If you or a family member was injured while taking one of these prescription drugs, please contact us for a free consultation.